Mangoceuticals (MGRX) Other Non Operating Income (2025)
Mangoceuticals' (MGRX) quarterly Other Non Operating Income came in at $106237.0 in Q4 2025, up 184.57% quarter-over-quarter from -$125625.0 in Q2 2025.
Mangoceuticals (MGRX) Other Non Operating Income (2025) Analysis & Trends
Mangoceuticals has disclosed Other Non Operating Income across 1 years of filings, most recently posting $106237.0 for Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn |
| 10 | Mangoceuticals | 5.25 Mn | 5.06 Mn | 29,001.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 106,237.00 |
| Jun 30, 2025 | -125,625.00 |